Patient sources of drug information and attitudes to their provision: a corticosteroid model

Aim: To determine patients' preferred sources of drug information and their attitudes to how this is provided.Design: A quantitative evaluation via personal interviews using a formal questionnaire.Subject and settings: A group of 101 in‐patients in a chest ward at the Royal Devon & Exeter Healthcare NHS Trust.Outcome measures: Preferred sources for medication advice; personal involvement in own treatment; adequacy of consultation period; medication compliance; post discharge sources of drug information; recalled benefits and side effects of corticosteroids.Results: Preferred source of drug information was: doctor (35%), pharmacist (11%) and nurse 4%. Sixty percent of patients wanted to be involved in the choice of their medication, thirty‐nine percent leaving it totally to the doctor and one patient who wanted the final word in what was prescribed. Sufficient discussion time with GPs was reported by 66% of patients (12%, insufficient) and 53% with hospital doctors (19%, insufficient). Non‐compliance with medication was reported by 66% and compliance by 24%. Medication advice sources used when at home were; community pharmacists (22%), GPs/books & magazines/specialist societies (all 18%), nurses (10%) and others less than 8%. Benefits of corticosteroids recalled by patients were: 'improving breathing' (14), 'general improvement' (9) and 'improved mobility'/'greater appetite' (both 5) 'with little change' reported by 13. Knowledge of side effects was much more comprehensive with; oedema/weight gain (50), skin/hair problems (33), osteoporosis (33), bruising (12) and mood changes (10) most commonly featured in responses. Almost all patients confirmed they liked to be given printed information about their medication.Conclusion: Patients sought their medication advice from a variety of sources and armed with this almost two thirds of patients wished to exercise their rights to be involved with their treatment planning. Sufficient discussion time appeared to be available to about half of the interviewees though only a few understood the intended benefits of prescribed corticosteroids used as an example in this work. A much better knowledge of drug side effects might have partly explained the high level of declared non‐compliance. Although pharmacists featured as the preferred source of drug information for some patients, a much more detailed investigation is needed of patients' attitudes to the profession and to individuals' consultation and communication skills.

[1]  K. Hassell,et al.  Advice-giving in Community Pharmacies in the UK , 1997, Journal of health services research & policy.

[2]  D. Reid,et al.  Steroid induced osteoporosis: an opportunity for prevention? , 1995, Annals of the rheumatic diseases.

[3]  D. Luscombe,et al.  Use of non‐prescription advice offered to the public by community pharmacists , 1997 .

[4]  P. Rowe,et al.  Pharmacists' engagement in continuing education and attitudes towards continuing professional development , 2002 .

[5]  A. Pilnick ‘Why Didn’t You Say Just That?’ Dealing with Issues of Asymmetry, Knowledge and Competence in the Pharmacist/client Encounter , 1998 .

[6]  L. Fallowfield The ideal consultation. , 1992, British journal of hospital medicine.

[7]  E. Barrett-Connor,et al.  Timing of postmenopausal estrogen for optimal bone mineral density. The Rancho Bernardo Study. , 1997, JAMA.

[8]  R. Epstein,et al.  Soliciting the Patient's Agenda , 2005 .

[9]  P. Ley,et al.  Improving patients’ understanding, recall, satisfaction and compliance , 1989 .

[10]  W. McNicholas,et al.  A one-year prospective audit of an asthma education programme in an out-patient setting. , 1996, Irish medical journal.

[11]  M. Pringle,et al.  Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross-sectional study , 1997 .

[12]  O. Hargie,et al.  CONSUMER PERCEPTIONS OF AND ATTITUDES TO COMMUNITY PHARMACY SERVICES , 1992 .

[13]  L. Ried,et al.  Patients' satisfaction and their perception of the pharmacist. , 1999, Journal of the American Pharmaceutical Association.

[14]  J. Bland,et al.  A randomized controlled evaluation of specialist nurse education following accident and emergency department attendance for acute asthma. , 2000, Respiratory medicine.

[15]  W. Waters,et al.  Prescription Information Leaflets: A National Survey , 1990, Journal of the Royal Society of Medicine.

[16]  Barbara Gandek,et al.  Patient and Visit Characteristics Related to Physicians' Participatory Decision-Making Style: Results from the Medical Outcomes Study , 1995, Medical care.

[17]  F. Lang,et al.  Agenda setting in the patient-physician relationship. , 1999, JAMA.

[18]  D. Donaghy The asthma specialist and patient education. , 1995, Professional nurse.

[19]  A. Gafni,et al.  A Bedside Decision Instrument To Elicit a Patient's Preference Concerning Adjuvant Chemotherapy for Breast Cancer , 1992, Annals of Internal Medicine.

[20]  R. Frankel,et al.  The effect of physician behavior on the collection of data. , 1984, Annals of internal medicine.

[21]  W. Waters,et al.  Knowledge of and attitudes to medicines in the Southampton community. , 1986, British journal of clinical pharmacology.

[22]  C. O'neil,et al.  Impact of Patient Knowledge, Patient‐Pharmacist Relationship, and Drug Perceptions on Adverse Drug Therapy Outcomes , 1998, Pharmacotherapy.

[23]  J. McElnay,et al.  The role of the community pharmacist — a survey of public opinion in Northern Ireland , 1993 .

[24]  Barbara Gandek,et al.  Characteristics of Physicians with Participatory Decision-Making Styles , 1996, Annals of Internal Medicine.

[25]  S. Winn,et al.  Public views on an extended role for community pharmacy , 1992 .